readthroughSign in
CompanyMLYSNasdaqRadnor, PA

Mineralys Therapeutics

Mineralys Therapeutics develops oral aldosterone synthase inhibitors for hypertension, chronic kidney disease, and obstructive sleep apnea.

424B3Nov 12Latest SEC filing
Nov 4Latest story